Glooko announced today that it acquired Diabnext, a developer of a digital health platform for managing diabetes and connecting to healthcare providers.
Paris-based Diabnext’s mobile app tracks diabetes data so that physicians can collaborate with their patients to monitor individual patient data and provide remote care. Financial details of the acquisition were not disclosed.
Get the full story at our sister site, Drug Delivery Business News.